|
|
 |
SENSEX
|
 |
-213.65
|
-0.85%
|
24870.10
|
|
|
NIFTY
|
 |
-693.86
|
-0.85%
|
81306.85
|
|
|
Nasdaq
|
 |
396.23
|
1.88%
|
21496.54
|
|
|
Nikkei 225
|
 |
23.12
|
0.05%
|
42633.29
|
|
|
FTSE 100
|
 |
12.20
|
0.13%
|
9321.40
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cadila |
BSE Code |
532321
|
ISIN Demat |
INE010B01027
|
Book Value (Rs) |
214.41
|
|
NSE Code |
ZYDUSLIFE
|
Dividend Yield % |
1.11
|
Market Cap (Rs) |
994964.17
|
|
TTM PE(x) |
22.31
|
TTM EPS(Rs) |
44.31
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
15-05 1995
|
Registered Office
|
Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat-382481 .
|
ISINNO
|
INE010B01027
|
Phone
|
079-71800000 / 48040000
|
E-mail
|
dhavalsoni@zyduscadila.com |
URL
|
www.zyduscadila.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Pankaj R Patel
|
Managing Director
|
Sharvil P Patel
|
Company Secretary
|
Dhaval N Soni
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|